Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bellnier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Thoracic Disease|September 22, 2017
Endobronchial ultrasound-guidance for interstitial photodynamic therapy of locally advanced lung cancer-a new interventional conceptKassem Harris, Emily Oakley, David Bellnier, et al.
Photochemistry and Photobiology|May 18, 2011
Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responsesAllison Marrero, Theresa Becker, Ulas Sunar, et al.
Lasers in Surgery and Medicine|June 22, 2006
Endobronchial photodynamic therapy for lung cancerGregory M Loewen, Ravindra Pandey, David Bellnier, et al.
Cancers|January 27, 2017
Interstitial Photodynamic Therapy-A Focused ReviewGal Shafirstein, David Bellnier, Emily Oakley, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2020
TLD1433-Mediated Photodynamic Therapy with an Optical Surface Applicator in the Treatment of Lung Cancer Cells In VitroSarah Chamberlain, Houston D Cole, John Roque, et al.
Photodiagnosis and Photodynamic Therapy|April 28, 2018
Photodynamic therapy does not induce cyclobutane pyrimidine dimers in the presence of melaninShaila Mudambi, Paula Pera, Deschana Washington, et al.
Photochemistry and Photobiology|December 31, 2019
Irradiance, Photofrin<sup>®</sup> Dose and Initial Tumor Volume are Key Predictors of Response to Interstitial Photodynamic Therapy of Locally Advanced Cancers in Translational ModelsEmily Oakley, David Bellnier, Alan Hutson, et al.
Photodermatology, Photoimmunology & Photomedicine|August 15, 2022
KDM1A inhibition increases UVA toxicity and enhances photodynamic therapy efficacyShaila Mudambi, Megan Fitzgerald, Paula Pera, et al.
Photochemistry and Photobiology|May 13, 2025
Image-based treatment planning for TLD1433 mediated intraoperative photodynamic therapy with an optical surface applicator-A translational rodent studySarah Chamberlain, Ge Shi, Sandra Sexton, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2011
Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapyLyudmila G Burdelya, Anatoli S Gleiberman, Ilia Toshkov, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|September 22, 2017
Endobronchial ultrasound-guidance for interstitial photodynamic therapy of locally advanced lung cancer-a new interventional conceptKassem Harris, Emily Oakley, David Bellnier, et al.
Photochemistry and Photobiology|May 18, 2011
Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responsesAllison Marrero, Theresa Becker, Ulas Sunar, et al.
Lasers in Surgery and Medicine|June 22, 2006
Endobronchial photodynamic therapy for lung cancerGregory M Loewen, Ravindra Pandey, David Bellnier, et al.
Cancers|January 27, 2017
Interstitial Photodynamic Therapy-A Focused ReviewGal Shafirstein, David Bellnier, Emily Oakley, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2020
TLD1433-Mediated Photodynamic Therapy with an Optical Surface Applicator in the Treatment of Lung Cancer Cells In VitroSarah Chamberlain, Houston D Cole, John Roque, et al.
Photodiagnosis and Photodynamic Therapy|April 28, 2018
Photodynamic therapy does not induce cyclobutane pyrimidine dimers in the presence of melaninShaila Mudambi, Paula Pera, Deschana Washington, et al.
Photochemistry and Photobiology|December 31, 2019
Irradiance, Photofrin<sup>®</sup> Dose and Initial Tumor Volume are Key Predictors of Response to Interstitial Photodynamic Therapy of Locally Advanced Cancers in Translational ModelsEmily Oakley, David Bellnier, Alan Hutson, et al.
Photodermatology, Photoimmunology & Photomedicine|August 15, 2022
KDM1A inhibition increases UVA toxicity and enhances photodynamic therapy efficacyShaila Mudambi, Megan Fitzgerald, Paula Pera, et al.
Photochemistry and Photobiology|May 13, 2025
Image-based treatment planning for TLD1433 mediated intraoperative photodynamic therapy with an optical surface applicator-A translational rodent studySarah Chamberlain, Ge Shi, Sandra Sexton, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2011
Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapyLyudmila G Burdelya, Anatoli S Gleiberman, Ilia Toshkov, et al.
Pageof 2